8 studies found for:    asg-5me
Show Display Options
Rank Status Study
1 Completed A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer
Condition: Prostate Neoplasms
Intervention: Drug: ASG-5ME
2 Completed A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma
Conditions: Gastric Neoplasms;   Pancreatic Neoplasms
Intervention: Drug: ASG-5ME
3 Recruiting ASG-15ME is a Study of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial Cancer
Condition: Metastatic Urothelial Cancer
Intervention: Drug: AGS15E
4 Active, not recruiting A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4
Conditions: Tumors;   Medical Oncology;   Neoplasms
Interventions: Drug: AGS-22M6E;   Drug: ASG-22CE
5 Recruiting AA Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
Condition: Metastatic Urothelial Cancer and Other Malignant Solid Tumors
Intervention: Drug: ASG-22CE
6 Completed Effectiveness of HIV/Sexually Transmitted Infection Training for Physicians in China
Conditions: HIV Infections;   Gonorrhea;   Chlamydia
Interventions: Behavioral: Physician Ai Shi Zi training;   Drug: Standard care;   Behavioral: Patient risk-reduction counseling
7 Unknown  RISCA : Prospective Study of Individuals at Risk for SCA1, SCA2, SCA3, SCA6, SCA7
Condition: Spinocerebellar Ataxias
Intervention:
8 Recruiting Intraoperative Radiotherapy for Korean Patients With Breast Cancer
Conditions: Breast Cancer;   Breast Conservative Surgery
Intervention: Device: Intraoperative radiotherapy using Intrabeam®

Indicates status has not been verified in more than two years